Benzinga | Nov 9, 2020 07:49AM EST

Wedbush Initiates Coverage On Codiak BioSciences with Outperform Rating, Announces Price Target of $19

Wedbush initiates coverage on Codiak BioSciences (NASDAQ:CDAK) with a Outperform rating and announces Price Target of $19.